Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy

NCT00936546 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT00936546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00936546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
Lead sponsor
University Hospital, Ghent
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2009
Completion date
June 3, 2015
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

debilitating fibrosing skin disorders (localised scleroderma, eosinophilic fasciitis)